US6037460A - Alkyl 2-acetamido-2-deoxyglucopyranoside uronic acids and their preparation - Google Patents

Alkyl 2-acetamido-2-deoxyglucopyranoside uronic acids and their preparation Download PDF

Info

Publication number
US6037460A
US6037460A US08/840,002 US84000297A US6037460A US 6037460 A US6037460 A US 6037460A US 84000297 A US84000297 A US 84000297A US 6037460 A US6037460 A US 6037460A
Authority
US
United States
Prior art keywords
acetamido
alkyl
reaction product
acid
deoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
US08/840,002
Other languages
English (en)
Inventor
Gunther Schneider
Hartmut Schmidt-Lewerkuhne
Joachim Thiem
Oliver Scheel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beiersdorf AG
Original Assignee
Beiersdorf AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beiersdorf AG filed Critical Beiersdorf AG
Assigned to BEIERSDORF AG reassignment BEIERSDORF AG ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: THIEM, JOACHIM, SCHEEL, OLIVER, SCHMIDT-LEWERKUHNE, HARTMUT, SCHNEIDER, GUNTHER
Priority to US09/470,775 priority Critical patent/US6156326A/en
Application granted granted Critical
Publication of US6037460A publication Critical patent/US6037460A/en
Priority to US09/660,224 priority patent/US6387961B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/10Washing or bathing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/602Glycosides, e.g. rutin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/005Preparations for sensitive skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/02Preparations for cleaning the hair
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/12Acyclic radicals, not substituted by cyclic structures attached to a nitrogen atom of the saccharide radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/14Acyclic radicals, not substituted by cyclic structures attached to a sulfur, selenium or tellurium atom of a saccharide radical
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S516/00Colloid systems and wetting agents; subcombinations thereof; processes of
    • Y10S516/905Agent composition per se for colloid system making or stabilizing, e.g. foaming, emulsifying, dispersing, or gelling
    • Y10S516/914The agent contains organic compound containing nitrogen, except if present solely as NH4+
    • Y10S516/915The compound contains -C[=O]NHH where substitution may be made for the hydrogen

Definitions

  • the present invention relates to novel active compounds, their preparation and their use in the field of cosmetic and of pharmaceutical dermatology.
  • the present invention relates to active compounds and cosmetic and dermatological preparations comprising such active compound combinations.
  • the present invention relates to active compounds which have surfactant properties.
  • the invention further relates to cosmetic and dermatological preparations which contain such substances.
  • the present invention relates to cosmetic cleansing agents.
  • Agents of this type are known per se. In this context, they are essentially surface-active substances or substance mixtures which are offered to the consumer in various preparations.
  • Preparations of this type are, for example, bubble baths and shower baths, solid and liquid soaps or so-called “syndets” (synthetic detergents), shampoos, hand-washing pastes, intimate cleansing agents, special cleansing agents for infants and the like.
  • solid and liquid soaps solid and liquid soaps or so-called “syndets” (synthetic detergents), shampoos, hand-washing pastes, intimate cleansing agents, special cleansing agents for infants and the like.
  • Cosmetic emulsions also contain interfacially active substances, so-called emulsifiers. These reduce the surfaces of contact between the phases and form oil/water interfacial films on the phase boundary. As a result, the irreversible confluence of the dispersed phase is counteracted.
  • Efficient emulsifiers are therefore distinguished by a very good emulsifying, solubilizing and dispersing ability. To a great extent, it is desirable that such substances do not cause skin irritation.
  • the choice of such substances known to the prior art is restricted. it was therefore an object of the present invention to enrich the prior art in this respect.
  • Preparations of this type are known per se. In this context, they are essentially surface-active substances or substance mixtures which are offered to the consumer in various preparations. Preparations of such a type are in general distinguished by a high water content to a greater or lesser degree, but can also be present, for example, as a concentrate.
  • preparations which are intended for the shower bath do not differ or hardly differ from bath preparations apart from the fact that in the case of shower preparations products of higher viscosity are preferred, which do not run from the hand after removal from the container. In the case of bath preparations, this is less of practical importance.
  • preparations of various types it being possible to vary the properties of the fat or oil phase by addition of surface-active substances.
  • preparations can be formulated which either produce spreading oil films, oil-in-water systems or even total solubilizates on the bath-water surface.
  • Foaming formulations but also only slightly foaming or non-foaming formulations, are possible.
  • the functionality of preparations of this type is restricted in oil bath or oil cream bath preparations to the refatting or superfatting of the uppermost layers of skin.
  • the present invention relates to cosmetic and dermatological preparations for the prophylaxis and treatment of cosmetic or dermatological cell changes, in particular skin changes such as, for example, skin ageing, in particular the cell ageing caused by oxidative processes, in particular skin ageing.
  • alkyl 2-acetamido-2-deoxy-D-glucopyranoside uronic acids of the general formula ##STR1## where R is representative of the group consisting of branched and unbranched alkyl of 1-48 C atoms, in particular of 14-22, preferably 16-18, C atoms, and their salts, and a process for the preparation of alkyl 2-acetamido-2-deoxy-D-glucopyranoside uronic acids of the general formula ##STR2## where R is representative of the group consisting of branched and unbranched alkyl of 1-48 C atoms, in particular of 14-22, preferably 16-18, C atoms, and their salts, characterized in that
  • reaction product thus obtained is purified by dialysis, preferably electrodialysis,
  • alkyl 2-acetamido-2-deoxy-D-glucopyranaside uronic acids of the general formula ##STR3## where R is representative of the group consisting of branched and unbranched alkyl of 1-48 C atoms, in particular of 14-22, preferably 16-18, C atoms, as surface-active and/or interfacially active active compounds, in particular as detergent surfactants or emulsifiers, and where the uronic acids can preferably be present in the form of their salts, in particular as alkali metal salts, of these preferably the sodium salt, or as ammonium, alkylammonium, dialkylammonium, trialkylammonium or tetraalkylammonium salts.
  • Mixtures of ⁇ - and ⁇ -glycosides can also be advantageous according to the invention.
  • a plethora of processes which are able to separate the anomers are known to the person skilled in the art, for example chromatographic processes.
  • alkyl 2-acetamido-2-deoxy-D-glucopyranoside uronic acids and their advantageous salts according to the invention are derived formally as well as practically from chitin, which is characterized by the structural formula ##STR4##
  • chitin derivatives namely of chitosan, a hydrolysis product of chitin
  • chitin for example, is better suited than the chitin on which it is based, as a thickener or stabilizer and improves the adhesion and water-resistance of polymeric films. Representing a multiplicity of places where this is found in the prior art: H. P. Fiedler, "Lexikon der Hilfstoffe fur Pharmazie, Kosmetik und angrenzende füre" [Encyclopedia of auxiliaries for pharmacy, cosmetics and neighbouring fields], 4th Edition 1989, Editio Cantor, Aulendorf, p. 349, headword "Chitosan”.
  • the ground chitin is treated in the presence of heat, advantageously at temperatures of 40-70° C., in particular about 55° C., with acid and a first aliphatic alcohol.
  • a suitable temperature range for this reaction step and for the distillative removal of the first aliphatic alcohol is between 80 and 100° C., preferably about 90° C.
  • the acid catalysis can be carried out on acidic ion-exchange resins, e.g. Amberlite IR 120, by means of camphorsulphonic acid or hydrochloric acid.
  • acidic ion-exchange resins e.g. Amberlite IR 120
  • camphorsulphonic acid or hydrochloric acid e.g. camphorsulphonic acid or hydrochloric acid.
  • a neutralisation can advantageously be carried out, e.g. using sodium hydroxide solution or on basic ion-exchange resins.
  • an anomer mixture is obtainable which can be separated into the anomers by methods familiar to the person skilled in the art.
  • the ⁇ -anomer is obtained, usually in a nine-fold excess compared with the ⁇ -anomer.
  • alkyl 2-acetamido-2-deoxyglucopyranosides which are known per se are also outstandingly suitable as surface-active or interfacially active substances. Therefore, also according to the invention is the use of alkyl 2-acetamido-2-deoxyglucopyranosides of the general structural formula ##STR7## where R is representative of the group consisting of branched and unbranched alkyl of 1-48 C atoms, in particular of 14-22, preferably 16-18, C atoms, as surface-active and/or interfacially active active compounds, in particular as detergent surfactants or emulsifiers.
  • the cosmetic or dermatological formulations according to the invention can be made up in the customary manner and used for the treatment, the care and the cleansing of the skin and/or the hair and as a make-up product in decorative cosmetics. They preferably contain 0.001% by weight to 10% by weight, but in particular 0.01% by weight to 6% by weight, based on the total weight of the composition, of the alkyl 2-acetamido-2-deoxy-D-glucopyranoside uronic acids according to the invention.
  • the cosmetic and dermatological preparations according to the invention are applied to the skin and/or the hair in adequate amounts in the manner customary for cosmetics.
  • Cosmetic and dermatological preparations according to the invention can be present in various forms.
  • alkyl 2-acetamido-2-deoxy-D-glucopyranoside uronic acids according to the invention to aqueous systems or surfactant preparations for cleansing the skin and the hair.
  • the cosmetic and dermatological preparations according to the invention can contain cosmetic auxiliaries, such as are customarily used in such preparations, e.g. preservatives, bactericides, perfumes, substances for preventing foaming, colourants, pigments which have a colouring action, thickening agents, surface-active substances, emulsifiers, emollient, moisturizing and/or moisture-retaining substances, fats, oils, waxes or other customary constituents of a cosmetic or dermatological formulation such as alcohols, polyols, polymers, foam stabilizers, electrolytes, organic solvents or silicone derivatives.
  • cosmetic auxiliaries such as are customarily used in such preparations, e.g. preservatives, bactericides, perfumes, substances for preventing foaming, colourants, pigments which have a colouring action, thickening agents, surface-active substances, emulsifiers, emollient, moisturizing and/or moisture-retaining substances, fats, oils, waxes or other
  • alkyl 2-acetamido-2-deoxy-D-glucopyranoside uronic acids can also be combined with antioxidants.
  • convenient antioxidants which can be used are all antioxidants suitable or customary for cosmetic and/or dermatological applications.
  • the antioxidants are selected from the group consisting of amino acids (e.g. glycine, histidine, tyrosine, tryptophan) and their derivatives, imidazoles (e.g. urocaninic acid) and their derivatives, peptides such as D,L-carnosine, D-carnosine, L-carnosine and their derivatives (e.g. anserine), carotenoids, carotenes (e.g. ⁇ -carotene, ⁇ -carotene, lycopene) and their derivatives, chlorogenic acid and its derivatives, lipoic acid and its derivatives (e.g.
  • amino acids e.g. glycine, histidine, tyrosine, tryptophan
  • imidazoles e.g. urocaninic acid
  • peptides such as D,L-carnosine, D-carnosine, L-carnosine and their derivatives (e.g. anserine)
  • thiols e.g. thioredoxin, glutathione, cysteine, cystine, cystamine and their glycosyl, N-acetyl, methyl, ethyl, propyl, amyl, butyl and lauryl, palmitoyl, oleyl, ⁇ -linoleyl, cholesteryl and glyceryl esters
  • salts dilauryl thiodipropionate, distearyl thiodipropionate, thiodipropionic acid and its derivatives (esters, ethers, peptides, lipids, nucleotides, nucleosides and salts) as well as sulphoximine compounds (e.g.
  • buthionine sulphoximine in very low tolerable doses (e.g. pmol to ⁇ mol/kg), furthermore (metal) chelators (e.g. ⁇ -hydroxy fatty acids, palmitic acid, phytic acid, lactoferrin), ⁇ -hydroxy acids (e.g. citric acid, lactic acid, maleic acid), humic acid, bile acid, bile extracts, bilirubin, biliverdin, EDTA, EGTA and their derivatives, unsaturated fatty acids and their derivatives (e.g.
  • metal chelators e.g. ⁇ -hydroxy fatty acids, palmitic acid, phytic acid, lactoferrin
  • ⁇ -hydroxy acids e.g. citric acid, lactic acid, maleic acid
  • humic acid bile acid, bile extracts, bilirubin, biliverdin, EDTA, EGTA and their derivatives, unsaturated fatty acids and their
  • ⁇ -linolenic acid linoleic acid, oleic acid
  • folic acid and its derivatives ubiquinone and ubiquinol and their derivatives
  • vitamin C and derivatives e.g. ascorbyl palmitate, Mg-ascorbyl phosphate, ascorbyl acetate
  • tocopherols and derivatives e.g.
  • vitamin E acetate
  • vitamin A and derivatives vitamin A palmitate
  • coniferyl benzoate of benzoin rutic acid and its derivatives, ⁇ -glycosylrutin, ferulic acid, furfurylidenglucitol, carnosine, butylhydroxytoluene, butylhydroxyanisole, nordihydroguairetic acid, trihydroxybutyrophenone, uric acid and its derivatives, mannose and its derivatives, zinc and its derivatives (e.g. ZnO, ZnSO 4 ), selenium and its derivatives (e.g. selenomethionine), stilbenes and their derivatives (e.g. stilbene oxide, trans-stilbene oxide) and the suitable derivatives according to the invention (salts, esters, ethers, sugars, nucleotides, nucleosides, peptides and lipids) of these mentioned active compounds.
  • the amount of the abovementioned antioxidants (one or more compounds) in the preparations is preferably 0.001 to 300% by weight, particularly preferably 0.05-20% by weight, in particular 1-10% by weight, based on the total weight of the preparation.
  • vitamin E and/or its derivatives are the antioxidant(s), it is advantageous to select their respective concentrations from the range from 0.001-10% by weight, based on the total weight of the formulation.
  • vitamin A, or vitamin A derivatives, or carotenes or their derivatives are the antioxidant(s) it is advantageous to select their respective concentrations from the range from 0.001-100% by weight, based on the total weight of the formulation.
  • Emulsions according to the invention are advantageous and contain, for example, the fats, oils, waxes and other fatty materials mentioned, as well as water and an emulsifier, such as is customarily used for such a type of formulation.
  • oils such as triglycerides of capric or of caprylic acid, but preferably castor oil;
  • esters of fatty acids with alcohols of low C number e.g. with isopropanol, propylene glycol or glycerol, or esters of fatty alcohols with alkanoic acids of low C number or with fatty acids;
  • silicone oils such as dimethylpolysiloxanes, diethylpolysiloxanes, diphenylpolysiloxanes as well as mixed forms thereof;
  • saturated compounds such as hydrocarbons of natural or synthetic origin (petroleum jelly, squalane).
  • the aqueous phase of the preparations according to the invention if desired advantageously contains alcohols, diols or polyols of low C number, as well as their ethers, preferably ethanol, isopropanol, propylene glycol, glycerol, ethylene glycol, ethylene glycol monoethyl or monobutyl ether, propylene glycol monomethyl, monoethyl or monobutyl ether, diethylene glycol monomethyl or monoethyl ether and analogous products and also, in particular, one or more thickening agents, which can advantageously be selected from the group consisting of silica, aluminium silicates, polysaccharides and their derivatives, e.g.
  • hyaluronic acid, xanthan gum, hydroxypropylmethylcellulose particularly advantageously from the group consisting of the polyacrylates, preferably a polyacrylate from the group consisting of the so-called carbopols, for example carbopols of the types 980, 981, 1382, 2984, 5984, in each case individually or in combination.
  • mixtures of the abovementioned solvents are used.
  • water can be a further constituent.
  • Gels according to the invention customarily contain alcohols of low C number, e.g. ethanol, isopropanol, 1,2-propanediol, glycerol and water or an above-mentioned oil in the presence of a thickening agent which in the case of oily-alcoholic gels is preferably silica or an aluminium silicate, and in the case of aqueous-alcoholic or alcoholic gels preferably a polyacrylate.
  • alcohols of low C number e.g. ethanol, isopropanol, 1,2-propanediol, glycerol and water or an above-mentioned oil
  • a thickening agent which in the case of oily-alcoholic gels is preferably silica or an aluminium silicate, and in the case of aqueous-alcoholic or alcoholic gels preferably a polyacrylate.
  • Suitable propellants for preparations according to the invention which can be sprayed from aerosol containers are the customary known easily volatile, liquefied propellants, for example hydrocarbons (propane, butane, isobutane), which can be employed on their own or as a mixture with one another. Compressed air can also advantageously be used.
  • preparations according to the invention can additionally contain substances which absorb UV radiation in the UVB range, the total amount of the filter substances being, for example, 0.1% by weight to 30% by weight, preferably 0.5 to 10% by weight, in particular 1.0 to 6.0% by weight, based on the total weight of the preparations, in order to make available cosmetic preparations which protect the hair or the skin from the entire range of ultraviolet radiation. They can also be used as sunscreens for the hair or the skin.
  • UVB filter substances these can be oil-soluble or water-soluble.
  • Advantageous oil-soluble UVB filters according to the invention are, for example:
  • 3-benzylidencamphor derivatives preferably 3-(4-methylbenzylidene)camphor, 3-benzylidenecamphor;
  • 4-aminobenzoic acid derivatives preferably 2-ethylhexyl 4-dimethylaminobenzoate, amyl 4-dimethylaminobenzoate;
  • esters of cinnamic acid preferably 2-ethylhexyl 4-methoxycinnamate, isopentyl 4-methoxycinnamate;
  • esters of salicylic acid preferably 2-ethylhexyl salicylate, 4-isopropylbenzyl salicylate, homomenthyl salicylate;
  • benzophenone preferably 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone, 2,2'-dihydroxy-4-methoxybenzophenone;
  • esters of benzylidenemalonic acid preferably di(2-ethylhexyl) 4-methyoxybenzylidenemalonate, 2,4,6-trianilino-(p-carbo-2'-ethyl-1'-hexyloxy)-1,3,5-triazine.
  • Advantageous water-soluble UVB filters are, for example:
  • 2-phenylbenzimidazole-5-sulphonic acid such as its sodium, potassium or its triethanolammonium salt, as well as the sulphonic acid itself;
  • sulphonic acid derivatives of benzophenone preferably 2-hydroxy-4-methoxybenzophenone-5-sulphonic acid and its salts
  • sulphonic acid derivatives of 3-benzylidenecamphor such as, for example, 4-(2-oxo-3-bornylidenemethyl)-benzenesulphonic acid, 2-methyl-5-(2-oxo-3-bornylidenemethyl)sulphonic acid and their salts.
  • UVB filters which can be used in combination with the alkyl 2-acetamido-2-deoxy-D-glucopyranoside uronic acids according to the invention, should of course be non-limiting.
  • the invention also relates to the use of a combination of the alkyl 2-acetamido-2-deoxy-D-glucopyranoside uronic acids according to the invention with at least one UVB filter as antioxidant or the use of a combination of the tocopherylglycosides according to the invention with at least one UVB filter as antioxidant in a cosmetic or dermatological preparation.
  • alkyl 2-acetamido-2-deoxy-D-glucopyranoside uronic acids according to the invention with UVA filters which to date are customarily contained in cosmetic preparations.
  • These substances are preferably derivatives of dibenzoylmethane, in particular 1-(4'-tert-butylphenyl)-3-(4'-methoxyphenyl)propane-1,3-dione and 1-phenyl-3-(4'-isopropylphenyl)propane-1,3-dione.
  • These combinations and preparations which contain these combinations are also a subject of the invention.
  • the amounts used for the UVB combination can be employed.
  • the invention also relates to the use of a combination of the alkyl 2-acetamido-2-deoxy-D-glucopyranoside uronic acids according to the invention with at least one UVA filter as antioxidant or the use of a combination of the tocopherylgycosides according to the invention with at least one UVA filter as antioxidant in a cosmetic or dermatological preparation.
  • the invention also relates to the use of a combination of the alkyl 2-acetamido-2-deoxy-D-glucopyranoside uronic acids according to the invention with at least one UVA filter and at least one UVB filter as antioxidant or the use of a combination of the tocopherylglycosides according to the invention with at least one UVA filter and at least one UVB filter as antioxidant in a cosmetic or dermatological preparation.
  • Cosmetic and dermatological preparations having an efficacious content of alkyl 2-acetamido-2-deoxy-D-glucopyranoside uronic acids according to the invention can also contain inorganic pigments which are customarily used in cosmetics for the protection of the skin from UV rays.
  • inorganic pigments which are customarily used in cosmetics for the protection of the skin from UV rays.
  • these are oxides of titanium, zinc, iron, zirconium, silicon, manganese, aluminium, cerium and mixtures thereof, as well as modifications in which the oxides are the active agents.
  • they are pigments based on titanium dioxide.
  • UVA filter and pigment or preparations which contain this combination are also a subject of the invention.
  • the amounts mentioned for the above combinations can be used.
  • Cosmetic and dermatological preparations for the protection of the hair from UV rays according to the invention are, for example, shampoos, preparations which are applied when rinsing the hair before or after shampooing, before or after permanent wave treatment, or before or after dyeing or bleaching hair, preparations for hot-air drying or setting of the hair, preparations for dyeing or bleaching, a hairdressing and treatment lotion, a hair lacquer or permanent wave compositions.
  • the cosmetic and dermatological preparations contain active compounds and auxiliaries, such as are customarily used for this type of preparations for hair care and hair treatment.
  • auxiliaries used are preservatives, surface-active substances, substances for preventing foaming, thickening agents, emulsifiers, fats, oils, waxes, organic solvents, bactericides, perfumes, dyes or pigments whose object is to colour the hair or the cosmetic or dermatological preparation itself, electrolytes and substances preventing the hair from becoming greasy.
  • Electrolytes within the meaning of the present invention are water-soluble alkali metal, ammonium, alkaline earth metal (including magnesium) and zinc salts of inorganic anions and any desired mixtures of those salts, where it must be guaranteed that these salts are distinguished by pharmaceutical or cosmetic acceptability.
  • the anions according to the invention are preferably selected from the group consisting of the chlorides, the sulphates and hydrogen sulphates, the phosphates, hydrogen phosphates and the linear and cyclic oligophosphates as well as the carbonates and hydrogen carbonates.
  • Cosmetic preparations which are a skin-cleansing agent or shampoo preferably contain at least one further anionic, non-ionic or amphoteric and surface-active substance or surface-active betaines, or alternatively mixtures of such substances, furthermore alkyl 2-acetamido-2-deoxy-D-glucopyranoside uronic acids according to the invention in aqueous medium and auxiliaries, such as are customarily used for this purpose.
  • the surface-active substance or the mixtures of these substances can be present in a concentration of between 1% by weight and 50% by weight in the shampoo.
  • the cosmetic or dermatological preparations are present in the form of a lotion which is rinsed out and is applied, for example, before or after bleaching, before or after shampooing, between two shampooing steps, or before or after permanent wave treatment, they are in this case, for example, aqueous or aqueous-alcoholic solutions which optionally contain surface-active substances whose concentration can be between 0.1 and 10% by weight, preferably between 0.2 and 5% by weight.
  • These cosmetic or dermatological preparations can also be aerosols containing the auxiliaries customarily used for this purpose.
  • a cosmetic preparation in the form of a lotion which is not rinsed out in particular a lotion for setting the hair, a lotion which is used during hot-air drying of the hair, or a hairdressing and treatment lotion, is in general an aqueous, alcoholic or aqueous-alcoholic solution and contains at least one cationic, anionic, non-ionic or amphoteric polymer or alternatively mixtures thereof, as well as active compound combinations according to the invention in an efficacious concentration.
  • the amount of the polymers used is, for example, between 0.1 and 10% by weight, preferably between 0.1 and 3% by weight.
  • Cosmetic preparations for the treatment and care of the skin and of the hair which contain alkyl 2-acetamido-2-deoxy-D-glucopyranoside uronic acids according to the invention can be present as emulsions which are of the non-ionic or cationic type.
  • non-ionic emulsions contain oils or fatty alcohols which, for example, can also be polyethoxylated or polypropoxylated, or alternatively mixtures of both organic components.
  • These emulsions optionally contain cationic surface-active substances.
  • cosmetic preparations for the treatment and care of the hair can also be present as gels which, besides an efficacious content of alkyl 2-acetamido-2-deoxy-D-glucopyranoside uronic acids according to the invention, preferably contain water, further organic thickening agents, e.g. gum arabic, xanthan gum, sodium alginate, cellulose derivatives, preferably methylcellulose, hydroxymethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose or inorganic thickening agents, e.g. aluminium silicates such as, for example, bentonites, or a mixture of polyethylene glycol and polyethylene glycol stearate or distearate.
  • the thickening agent is contained in the gel, for example, in an amount of between 0.1 and 30% by weight, preferably of between 0.5 and 15% by weight.
  • the amount of the alkyl 2-acetamido-2-deoxy-D-glucopyranoside uronic acids according to the invention in a composition intended for the hair is 0.05% by weight to 10% by weight, in particular 0.5% by weight to 5% by weight, based on the total weight of the composition.
  • Aqueous cosmetic cleansing agents according to the invention or cleansing agent concentrates which are low in water or water-free intended for aqueous cleansing can contain anionic, non-ionic and/or amphoteric surfactants, for example conventional soaps, e.g. fatty acid salts of sodium, alkyl sulphates, alkyl ether sulphates, alkane- and alkylbenzenesulphonates, sulphoacetates, sulphobetaines, sarcosinates, amidosulphobetaines, sulphosuccinates, sulphosuccinic acid monoesters, alkyl ether carboxylates, protein-fatty acid condensates, alkylbetaines and amidobetaines, fatty acids alkanolamides and/or polyglycol ether derivatives.
  • anionic, non-ionic and/or amphoteric surfactants for example conventional soaps, e.g. fatty acid salts of sodium, alkyl s
  • Cosmetic preparations which are cosmetic cleansing preparations for the skin can be present in liquid or solid form.
  • these alkyl 2-acetamido-2-deoxy-D-glucopyranoside uronic acids according to the invention or their salts they can preferably contain at least one anionic, non-ionic or amphoteric surface-active substance or mixtures thereof, and if desired one or more electrolytes and auxiliaries, such as are customarily used for this purpose.
  • the surface-active substance can be present in a concentration of between 1 and 94% by weight in the cleansing preparations, based on the total weight of the preparations.
  • cosmetic preparations which are a shampoo preferably contain at least one anionic, non-ionic or amphoteric surface-active substance or mixtures thereof, and if desired an electrolyte and auxiliary according to the invention, such as are customarily used for this purpose.
  • the surface-active substance can be present in a concentration of between 1% by weight and 94% by weight in the shampoo.
  • compositions according to the invention contain water and, if desired, the additives customary in cosmetics, for example perfume, thickener, colourants, antimicrobial substances, refatting agents, complexing and sequestering agents, pearl lustre agents, plant extracts, vitamins, active compounds and the like.
  • the additives customary in cosmetics for example perfume, thickener, colourants, antimicrobial substances, refatting agents, complexing and sequestering agents, pearl lustre agents, plant extracts, vitamins, active compounds and the like.
  • the amount of alkyl 2-acetamido-2-deoxy-D-glucopyranoside uronic acids used according to the invention in these preparations is 0.001% by weight to 10% by weight, in particular 0.1% by weight to 3% by weight, based on the total weight of the preparations.
  • the invention also relates to the process for the preparation of the cosmetic compositions according to the invention, which is characterized in that alkyl 2-acetamido-2-deoxy-D-glucopyranoside uronic acids are incorporated into cosmetic and dermatological formulations in a manner known per se.
  • Ground chitin is treated at 55° C. with hydrochloric acid and butyl alcohol and the reaction product thus obtained is purified by electrodialysis.
  • the reaction product is reacted with stearyl alcohol with acid catalysis with camphorsulphonic acid at 90° C. and the butyl alcohol is stripped off under a water-jet vacuum at 90° C.
  • the product is neutralized with NaOH and the product is oxidized to the final product at 60° C. using Adam's catalyst.
  • Ground chitin is treated at 55° C. with hydrochloric acid and butyl alcohol and the reaction product thus obtained is purified by electrodialysis.
  • the reaction product is reacted with cetyl alcohol with acid catalysis with camphorsulphonic acid at 90° C. and the butyl alcohol is stripped off under a water-jet vacuum at 90° C.
  • the product is neutralized with NaOH and the product is oxidized to the final product at 60° C. using Adam's catalyst.
  • Ground chitin is treated at 55° C. with hydrochloric acid and butyl alcohol and the reaction product thus obtained is purified by electrodialysis.
  • the reaction product is reacted with decyl alcohol with acid catalysis with camphorsulphonic acid at 90° C. and the butyl alcohol is stripped off under a water-jet vacuum at 90° C.
  • the product is neutralized with NaOH and the product is oxidized to the final product at 60° C. using Adam's catalyst.
  • Ground chitin is treated at 55° C. with hydrochloric acid and butyl alcohol and the reaction product thus obtained is purified by electrodialysis.
  • the reaction product is reacted with dodecyl alcohol with acid catalysis with camphorsulphonic acid at 90° C. and the butyl alcohol is stripped off under a water-jet vacuum at 90° C.
  • the product is neutralized with NaOH and the product is oxidized to the final product at 60° C. using Adam's catalyst.
  • Ground chitin is treated at 55° C. with hydrochloric acid and butyl alcohol and the reaction product thus obtained is purified by electrodialysis.
  • the reaction product is reacted with tetradecyl alcohol with acid catalysis with camphorsulphonic acid at 90° C. and the butyl alcohol is stripped off under a water-jet vacuum at 90° C.
  • the product is neutralized with NaOH and the product is oxidized to the final product at 60° C. using Adam's catalyst.
  • Ground chitin is treated at 55° C. with hydrochloric acid and butyl alcohol and the reaction product thus obtained is purified by electrodialysis.
  • the reaction product is reacted with palmityl alcohol with acid catalysis with camphorsulphonic acid at 90° C. and the butyl alcohol is stripped off under a water-jet vacuum at 90° C.
  • the product is neutralized with NaOH and the product is oxidized to the final product at 60° C. using Adam's catalyst.
  • Ground chitin is treated at 55° C. with hydrochloric acid and butyl alcohol and the reaction product thus obtained is purified by electrodialysis.
  • the reaction product is reacted with eicosyl alcohol with acid catalysis with camphorsulphonic acid at 90° C. and the butyl alcohol is stripped off under a water-jet vacuum at 90° C.
  • the product is neutralized with NaOH and the product is oxidized to the final product at 60° C. using Adam's catalyst.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)
US08/840,002 1996-04-27 1997-04-24 Alkyl 2-acetamido-2-deoxyglucopyranoside uronic acids and their preparation Expired - Fee Related US6037460A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US09/470,775 US6156326A (en) 1996-04-27 1999-12-23 Alkyl 2-acetamido-2-deoxyglucopyranoside uronic acids and derivatives, their preparation and their use as surfactants in cosmetic and pharmaceutical preparations
US09/660,224 US6387961B1 (en) 1996-04-27 2000-09-12 Alkyl 2-acetamido-2-deoxyglucopyranoside and methods of emulsifying

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19617019 1996-04-27
DE19617019A DE19617019A1 (de) 1996-04-27 1996-04-27 Alkyl-2-acetamino-2-desoxy-glucopyranosid-uronsäuren und -Derivate, ihre Herstellung sowie ihre Verwendung als Tenside in kosmetischen und pharmazeutischen Zubereitungen

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US09/470,775 Division US6156326A (en) 1996-04-27 1999-12-23 Alkyl 2-acetamido-2-deoxyglucopyranoside uronic acids and derivatives, their preparation and their use as surfactants in cosmetic and pharmaceutical preparations

Publications (1)

Publication Number Publication Date
US6037460A true US6037460A (en) 2000-03-14

Family

ID=7792727

Family Applications (3)

Application Number Title Priority Date Filing Date
US08/840,002 Expired - Fee Related US6037460A (en) 1996-04-27 1997-04-24 Alkyl 2-acetamido-2-deoxyglucopyranoside uronic acids and their preparation
US09/470,775 Expired - Fee Related US6156326A (en) 1996-04-27 1999-12-23 Alkyl 2-acetamido-2-deoxyglucopyranoside uronic acids and derivatives, their preparation and their use as surfactants in cosmetic and pharmaceutical preparations
US09/660,224 Expired - Fee Related US6387961B1 (en) 1996-04-27 2000-09-12 Alkyl 2-acetamido-2-deoxyglucopyranoside and methods of emulsifying

Family Applications After (2)

Application Number Title Priority Date Filing Date
US09/470,775 Expired - Fee Related US6156326A (en) 1996-04-27 1999-12-23 Alkyl 2-acetamido-2-deoxyglucopyranoside uronic acids and derivatives, their preparation and their use as surfactants in cosmetic and pharmaceutical preparations
US09/660,224 Expired - Fee Related US6387961B1 (en) 1996-04-27 2000-09-12 Alkyl 2-acetamido-2-deoxyglucopyranoside and methods of emulsifying

Country Status (4)

Country Link
US (3) US6037460A (fr)
EP (1) EP0808842A3 (fr)
JP (1) JPH1067629A (fr)
DE (1) DE19617019A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6387961B1 (en) * 1996-04-27 2002-05-14 Beiersdorf Ag Alkyl 2-acetamido-2-deoxyglucopyranoside and methods of emulsifying
US6623746B1 (en) * 1998-07-16 2003-09-23 Cognis Deutschland Gmbh & Co. Kg PIT emulsions, methods of softening paper using the same, and paper substrates treated therewith
WO2010076292A1 (fr) 2008-12-29 2010-07-08 Unilever Plc Compositions détergentes aqueuses structurées

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19802205A1 (de) 1998-01-22 1999-07-29 Beiersdorf Ag Kosmetische und dermatologische Zubereitungen, enthaltend erhöhte Elektrolytkonzentrationen
FR2785797B1 (fr) * 1998-11-12 2002-10-18 Oreal Compositions cosmetiques contenant un tensioactif ester d'alkylpolyglycoside anionique et un agent conditionneur liquide insoluble dans l'eau et leurs utilisations
FR2786187B1 (fr) * 1998-11-19 2001-11-09 Univ Paris Curie Composes du type 2-acylamino-2-deoxy-glucono-1,5-lactone, procede d'obtention, compositions les comportant et utilisations
DE19926170A1 (de) * 1999-06-09 2000-12-14 Beiersdorf Ag Haarkosmetische Mittel mit Ubichinonen
US20080153963A1 (en) * 2006-12-22 2008-06-26 3M Innovative Properties Company Method for making a dispersion
WO2008100798A1 (fr) 2007-02-09 2008-08-21 Primafuel, Inc. Procédé et appareil de production de biodiesel
DE102008024590B4 (de) * 2008-05-21 2017-06-01 Heraeus Deutschland GmbH & Co. KG Recycling-Verfahren für Katalysatorformkörper
US8137527B1 (en) 2008-07-28 2012-03-20 Primafuel, Inc. Carbon dioxide isolation and generation
CN107011395B (zh) * 2017-05-27 2020-01-03 湘潭大学 一类n-乙酰氨基葡萄糖苷类化合物

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2662073A (en) * 1951-04-27 1953-12-08 Charles L Mehltretter Gluconamides
US2783148A (en) * 1952-05-27 1957-02-26 American Home Prod Alcoholized chitin, process of preparation and food products containing the same
US2959583A (en) * 1959-01-23 1960-11-08 Warner Lambert Pharmaceutical Method of purifying sulfated polysaccharides
US4533549A (en) * 1983-01-04 1985-08-06 Lasker Sigmund E Antithrombotic agent
US4987223A (en) * 1981-12-23 1991-01-22 Choay S.A. Derivatives of the uronic acid
WO1993004662A1 (fr) * 1991-09-02 1993-03-18 Henkel Kommanditgesellschaft Auf Aktien Detergents doux
US5312907A (en) * 1991-10-08 1994-05-17 Akzo N.V. Glycosiduronic acids
FR2717176A1 (fr) * 1994-03-10 1995-09-15 Ard Dérivés d'acide (alkyl-D-glucofuranoside)uronique, procédé et intermédiaires de préparation et leurs applications.
US5539091A (en) * 1991-05-22 1996-07-23 Stepan Europe N-alkyl, n-acetylglycosylamines
US5696246A (en) * 1995-05-16 1997-12-09 Hoechst Aktiengesellschaft Process for the specific synthesis of β-glycosidically linked N-acetylpyranoside derivatives
US5773608A (en) * 1995-08-17 1998-06-30 Ciba Vision Corporation Process for preparing stabilized chitin derivative compounds

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5252882A (en) * 1975-10-28 1977-04-28 Toyo Ink Mfg Co Ltd Surfactants
JP2565513B2 (ja) * 1987-09-25 1996-12-18 三省製薬株式会社 メラニン生成抑制外用薬剤
JPH02273608A (ja) * 1989-04-17 1990-11-08 Taiyo Kagaku Co Ltd 色白化粧料
DE4110506A1 (de) * 1991-03-30 1992-10-01 Huels Chemische Werke Ag Emulgatoren zur herstellung von in der kosmetik oder medizin verwendbaren oel-in-wasser-emulsionen etherischer oele
US5728670A (en) * 1993-10-12 1998-03-17 Lever Brothers Company, Division Of Conopco, Inc. Enzymatically stable alkyl (alkyl glycosid) uronates as nonionic surfactants and a process for their manufacture
DE4338015A1 (de) * 1993-11-08 1995-05-11 Asta Medica Ag Verwendung von D-glucopyranuronsäuren und deren Derivaten zum Einbau in pharmakologisch wirksame Peptide und deren Salze
JPH07306450A (ja) * 1994-05-11 1995-11-21 Canon Inc カメラ
DE19617019A1 (de) * 1996-04-27 1997-11-06 Beiersdorf Ag Alkyl-2-acetamino-2-desoxy-glucopyranosid-uronsäuren und -Derivate, ihre Herstellung sowie ihre Verwendung als Tenside in kosmetischen und pharmazeutischen Zubereitungen
DE19634020A1 (de) * 1996-08-23 1998-02-26 Beiersdorf Ag Herstellung von Glycoglycerolipiden, deren Verwendung als Tenside sowie kosmetische oder dermatologische Zubereitungen, solche Glycoglycerolipide enthaltend

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2662073A (en) * 1951-04-27 1953-12-08 Charles L Mehltretter Gluconamides
US2783148A (en) * 1952-05-27 1957-02-26 American Home Prod Alcoholized chitin, process of preparation and food products containing the same
US2959583A (en) * 1959-01-23 1960-11-08 Warner Lambert Pharmaceutical Method of purifying sulfated polysaccharides
US4987223A (en) * 1981-12-23 1991-01-22 Choay S.A. Derivatives of the uronic acid
US4533549A (en) * 1983-01-04 1985-08-06 Lasker Sigmund E Antithrombotic agent
US5539091A (en) * 1991-05-22 1996-07-23 Stepan Europe N-alkyl, n-acetylglycosylamines
WO1993004662A1 (fr) * 1991-09-02 1993-03-18 Henkel Kommanditgesellschaft Auf Aktien Detergents doux
US5312907A (en) * 1991-10-08 1994-05-17 Akzo N.V. Glycosiduronic acids
FR2717176A1 (fr) * 1994-03-10 1995-09-15 Ard Dérivés d'acide (alkyl-D-glucofuranoside)uronique, procédé et intermédiaires de préparation et leurs applications.
US5696246A (en) * 1995-05-16 1997-12-09 Hoechst Aktiengesellschaft Process for the specific synthesis of β-glycosidically linked N-acetylpyranoside derivatives
US5773608A (en) * 1995-08-17 1998-06-30 Ciba Vision Corporation Process for preparing stabilized chitin derivative compounds

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Yoshikawa et al., Chemical Transformation of Uronic Acids leading to Aminocyclitols. IV. Synthesis of Hexaacetyl streptamine from N Acetyl D glucosamine by Means of Electrolytic Decarboxylation, Chem Pharm Bull, 29(9) 2582 2586 (Sep. 9, 1981). *
Yoshikawa et al., Chemical Transformation of Uronic Acids leading to Aminocyclitols. IV. Synthesis of Hexaacetyl-streptamine from N-Acetyl-D-glucosamine by Means of Electrolytic Decarboxylation, Chem Pharm Bull, 29(9) 2582-2586 (Sep. 9, 1981).

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6387961B1 (en) * 1996-04-27 2002-05-14 Beiersdorf Ag Alkyl 2-acetamido-2-deoxyglucopyranoside and methods of emulsifying
US6623746B1 (en) * 1998-07-16 2003-09-23 Cognis Deutschland Gmbh & Co. Kg PIT emulsions, methods of softening paper using the same, and paper substrates treated therewith
WO2010076292A1 (fr) 2008-12-29 2010-07-08 Unilever Plc Compositions détergentes aqueuses structurées
US8450260B2 (en) 2008-12-29 2013-05-28 Conopco, Inc. Structured aqueous detergent compositions

Also Published As

Publication number Publication date
US6387961B1 (en) 2002-05-14
EP0808842A3 (fr) 1998-09-23
US6156326A (en) 2000-12-05
EP0808842A2 (fr) 1997-11-26
DE19617019A1 (de) 1997-11-06
JPH1067629A (ja) 1998-03-10

Similar Documents

Publication Publication Date Title
US5891854A (en) Cosmetic formulations having an effective content of glycosyl glycerides
CA2612674C (fr) Compositions cosmetiques ou dermatologiques non irritantes
US6468551B1 (en) Cosmetic or dermatological preparations based on emulsifiers which are free from ethylene oxide and propylene oxide, for the preparation of microemulsion gels
EP0824915B1 (fr) Utilisation de glycoglycerolipides comme agents tensio-actifs et compositions cosmétiques ou dermatologiques les contenant
US6667044B1 (en) Cosmetic or dermatological gels based on microemulsions
DE4444238A1 (de) Kosmetische oder dermatologische Wirkstoffkombinationen aus Zimtsäurederivaten und Flavonglycosiden
DE10032964A1 (de) Verwendung von Kreatin und/oder Kreatingderivaten in kosmetischen oder dermatologischen Zubereitungen
US6037460A (en) Alkyl 2-acetamido-2-deoxyglucopyranoside uronic acids and their preparation
KR19990088175A (ko) 나노분산액의화장품최종제형에서의용도
EP0726273A1 (fr) Tocophénylglycosides, leur préparation et utilisation comme tensides, comme antioxidants et comme prophylactiques pour modification des cellules dans préparations cosmétiques et pharmaceutiques
EP1813255B1 (fr) Combinaison active stable contenant des dérivés de glucose tensioactifs et des hydroxyacides
DE10128910A1 (de) Verwendung von Wirkstoffkombinationen aus Arginin und Ascorbinsäure zur Hautstraffung
EP1084701A1 (fr) Emulsion H/E contenant un ou plusieurs bioquinones et un teneur de glycerine élevée
DE10039063A1 (de) Kosmetische und dermatologische Zubereitung mit einem Gehalt an Cyclodextrinen zur Beseitigung von Sebum
DE10032165A1 (de) Verwendung von physiologisch verträglichen Sulfinsäuren als Antioxidans oder Radikalfänger in kosmetischen oder dermatologischen Zubereitungen
DE19806946A1 (de) Kosmetische oder dermatologische Wirkstoffkombinationen aus mindestens einer Substanz gewählt aus der Gruppe, bestehend aus Carnitin und den Acylcarnitinen, und mindestens einem Retinoid sowie Zubereitungen mit einem Gehalt an solchen Wirkstoffkombinationen
EP1397119A2 (fr) Utilisation de polystyrene sulfonate de sodium pour raffermir la peau
DE19545107A1 (de) Verwendung eines wirksamen Gehaltes an Adenosin in kosmetischen oder dermatologischen Zubereitungen
DE19806889A1 (de) Verwendung von Acyl-Carnitin
EP0744175A2 (fr) Compositions cosmétiques et dermatologiques contenant des acides gras alpha-hydroxyliques
DE19739349A1 (de) Verwendung von Troxerutin als Antioxidans oder Radikalfänger in kosmetischen oder dermatologischen Zubereitungen
JP2001253817A (ja) コラーゲン合成促進剤およびその製造方法ならびにコラーゲン合成促進剤を含有する皮膚外用剤。
JPH0952817A (ja) 美白化粧料
EP0955038A1 (fr) Compositions cosmétiques et dermatologiques contenant des céramides
JP2001039816A (ja) コラーゲン架橋形成阻害剤

Legal Events

Date Code Title Description
AS Assignment

Owner name: BEIERSDORF AG, GERMANY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SCHNEIDER, GUNTHER;SCHMIDT-LEWERKUHNE, HARTMUT;THIEM, JOACHIM;AND OTHERS;REEL/FRAME:008949/0678;SIGNING DATES FROM 19970619 TO 19970625

FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

FPAY Fee payment

Year of fee payment: 4

REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Lapsed due to failure to pay maintenance fee

Effective date: 20080314